cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AA812626 | .b | 2612 to 2943 | 332 to 2 | 331/332 (99 %) | 0 diff (100 %id) | ||||
AA813461 | .o | 36 to 428 | 405 to 13 | AAA | 393/393 (100 %) | 0 diff (100 %id) | |||
AA346222 | NULL, omentum | .a | 428 to 580 | 1 to 153 | 153/153 (100 %) | 0 diff (100 %id) | |||
AA367840 | placenta | .b | 2644 to 2943 | 298 to 1 | 298/298 (100 %) | 2 diff (99.4 %id) | |||
AA378608 | synovial membrane | .a | 749 to 1039 | 1 to 292 | 292/292 (100 %) | 2 diff (99.4 %id) | |||
AJ707195 | heart | .k | 275 to 789 | 517 to 3 | Submitted on the opposite strand | 515/534 (96 %) | 3 diff (99.5 %id) | ||
AK001167 | .a | 1540 to 3092 | 1 to 1553 | available from FLJ, | 1553/1553 (100 %) | 2 diff (99.9 %id) | |||
AK025479 | .a | 966 to 3092 | 1 to 2127 | available from FLJ, AAA | 2127/2127 (100 %) | 1 diff (100.0 %id) | |||
AK056433 | .a | -11 to 3092 | 1 to 3104 | exact | tiling clone, available from FLJ, | 3104/3104 (100 %) | 0 diff (100 %id) | ||
AK090627 | .i-u | 1323 to 3608 | 1 to 2287 | S26R P57A P58T E59* | tiling clone, available from FLJ, | 2287/2287 (100 %) | 4 diff (99.9 %id) | ||
AK093941 | trachea | .h | 142 to 2213 | 1 to 2070 | exact | tiling clone, available from FLJ, | 2070/2070 (100 %) | 3 diff (99.9 %id) | |
AK128439 | thymus | .i-u | 1 to 3608 | 2 to 3607 | exact | tiling clone, available from FLJ, | 3607/3607 (100 %) | 6 diff (99.9 %id) | |
AK307766 | cerebellum | .b | 1 to 2941 | 5 to 2942 | exact | tiling clone, | 2942/2942 (100 %) | 2 diff (100.0 %id) | |
AK310466 | testis | .n | 1 to 891 | 2 to 892 | tiling clone, | 892/892 (100 %) | 1 diff (99.9 %id) | ||
AL137396 | testis | .a | 2208 to 3092 | 1 to 883 | available from DKFZ, AAA | 883/883 (100 %) | 2 diff (99.8 %id) | ||
AW602869 | breast | .b | 2295 to 2527 | 1 to 234 | 234/234 (100 %) | 18 diff (92.4 %id) | |||
AW798057 | uterus | .b | 2552 to 2917 | 372 to 9 | 364/376 (96 %) | 0 diff (100 %id) | |||
AW800070 | uterus | .a | 961 to 1184 | 229 to 8 | 222/259 (85 %) | 1 diff (99.7 %id) | |||
AW964160 | .a | 750 to 1464 | 1 to 715 | 715/716 (99 %) | 3 diff (99.6 %id) | ||||
AX746543 | .i-u | 1323 to 3608 | 1 to 2287 | S26R P57A P58T E59* | 2287/2287 (100 %) | 4 diff (99.9 %id) | |||
BC125108 | PCR rescued clones | .a | 67 to 2821 | 1 to 2755 | exact | 2755/2755 (100 %) | 1 diff (100.0 %id) | ||
BC125109 | PCR rescued clones | .a | 67 to 2821 | 1 to 2755 | exact | 2755/2755 (100 %) | 1 diff (100.0 %id) | ||
BE696780 | colon | .a | 510 to 787 | 17 to 294 | 279/294 (94 %) | 6 diff (98.0 %id) | |||
BE719057 | head_neck | .a | 1701 to 1852 | 156 to 5 | 152/156 (97 %) | 1 diff (99.4 %id) | |||
BE937614 | testis_normal | .a | 532 to 787 | 2 to 268 | 279/268 (104 %) | 56 diff (79.2 %id) | |||
BE939403 | uterus | .b | 2552 to 2917 | 372 to 9 | 364/376 (96 %) | 0 diff (100 %id) | |||
BF081182 | amnion_normal | .a | 508 to 787 | 1 to 281 | 281/281 (100 %) | 4 diff (98.6 %id) | |||
BF091052 | testis_normal | .a | 510 to 787 | 32 to 311 | 280/311 (90 %) | 13 diff (95.9 %id) | |||
BF325708 | amnion_normal | .a | 507 to 787 | 38 to 320 | 287/320 (89 %) | 10 diff (96.9 %id) | |||
BF808343 | colon_ins | .b | 2464 to 2779 | 349 to 32 | Submitted on the opposite strand | 318/360 (88 %) | 0 diff (100 %id) | ||
BF906454 | ovary | .a | 1976 to 2435 | 72 to 532 | 461/532 (86 %) | 10 diff (98.2 %id) | |||
BF906464 | ovary | .a | 1976 to 2416 | 71 to 512 | 442/512 (86 %) | 13 diff (97.5 %id) | |||
BF923970 | nervous_tumor | .a | 1339 to 1743 | 406 to 1 | Submitted on the opposite strand | 406/407 (99 %) | 10 diff (97.6 %id) | ||
BF933704 | nervous_tumor | .a | 1630 to 1752 | 126 to 7 | Submitted on the opposite strand | 120/126 (95 %) | 0 diff (100 %id) | ||
BF935406 | nervous_tumor | .k | 554 to 920 | 1 to 368 | 372/368 (101 %) | 16 diff (95.7 %id) | |||
BF985025 | uterus | .b | 2552 to 2917 | 372 to 9 | 364/376 (96 %) | 0 diff (100 %id) | |||
BF986696 | placenta_normal | .a | 1506 to 1745 | 10 to 249 | 240/249 (96 %) | 10 diff (96.0 %id) | |||
BG315038 | .b | 2692 to 2880 | 182 to 1 | 182/183 (99 %) | 9 diff (95.1 %id) | ||||
BI027437 | marrow | .j | 26 to 419 | 1 to 393 | 393/393 (100 %) | 3 diff (99.3 %id) | |||
DA050113 | .i-u | 1324 to 1888 | 2 to 567 | capped | 566/566 (100 %) | 3 diff (99.5 %id) | |||
DB296225 | .i-u | 3063 to 3608 | 547 to 1 | 547/547 (100 %) | 1 diff (99.9 %id) | ||||
BQ308569 | breast | .b | 2356 to 2912 | 584 to 26 | 559/604 (92 %) | 0 diff (100 %id) | |||
BQ361586 | ovary | .b | 2753 to 2880 | 28 to 157 | 130/157 (82 %) | 6 diff (96.2 %id) | |||
DA067842 | cerebellum | .i-u | 666 to 1141 | 2 to 477 | capped | 476/476 (100 %) | 1 diff (99.8 %id) | ||
DB297366 | cerebellum | .i-u | 3136 to 3608 | 471 to 1 | 471/473 (99 %) | 1 diff (99.8 %id) | |||
DC310901 | cerebellum | .b | 1 to 578 | 5 to 581 | 581/581 (100 %) | 1 diff (99.9 %id) | |||
DC341936 | thalamus | .b | 1 to 581 | 3 to 583 | tiling clone, | 583/583 (100 %) | 0 diff (100 %id) | ||
BX281496 | melanotic melanoma, skin | .a | 507 to 831 | 9 to 334 | 329/334 (98 %) | 6 diff (98.3 %id) | |||
BX281707 | embryonal carcinoma, cell line, testis | .a | 2000 to 2490 | 1 to 491 | 491/491 (100 %) | 1 diff (99.8 %id) | |||
C75014 | .b | 2518 to 2936 | 421 to 5 | 417/421 (99 %) | 0 diff (100 %id) | ||||
CN291099 | embryonic stem cells, DMSO-treated H9 cellline | .e | 1 to 736 | 1 to 736 | tiling clone, | 736/736 (100 %) | 0 diff (100 %id) | ||
CN365250 | embryonic stem cells, cell lines H1, H7, andH9 | .b | 2463 to 2941 | 477 to 1 | Submitted on the opposite strand | 477/477 (100 %) | 6 diff (98.8 %id) | ||
CN365251 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 2044 to 2723 | 13 to 692 | 680/692 (98 %) | 7 diff (99.0 %id) | |||
CN365252 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 1829 to 2532 | 17 to 720 | 704/720 (97 %) | 8 diff (98.9 %id) | |||
CN365253 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .f | 1 to 776 | 6 to 782 | tiling clone, | 782/786 (99 %) | 6 diff (99.3 %id) | ||
CN370122 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 12 to 725 | 1 to 714 | 714/714 (100 %) | 1 diff (99.9 %id) | |||
CN370123 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 39 to 610 | 1 to 572 | 572/572 (100 %) | 0 diff (100 %id) | |||
CN370124 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 49 to 799 | 1 to 750 | 750/750 (100 %) | 2 diff (99.8 %id) | |||
CN370125 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 1 to 596 | 8 to 603 | 603/603 (100 %) | 5 diff (99.2 %id) | |||
CN370126 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 74 to 542 | 1 to 470 | 470/470 (100 %) | 4 diff (99.2 %id) | |||
CN370127 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 74 to 645 | 1 to 573 | 573/573 (100 %) | 1 diff (99.9 %id) | |||
CN370128 | embryonic stem cells, DMSO-treated H9 cellline | .a | 67 to 341 | 1 to 275 | 275/275 (100 %) | 0 diff (100 %id) | |||
CN370129 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 11 to 727 | 1 to 717 | 717/717 (100 %) | 2 diff (99.8 %id) | |||
CR457343 | .a | 1031 to 2601 | 1 to 1571 | 1571/1575 (99 %) | 2 diff (99.9 %id) | ||||
AL527134 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .a | 1970 to 3061 | 1077 to 1 | 1077/1097 (98 %) | 18 diff (98.4 %id) | |||
AL527155 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .a | 46 to 1064 | 1 to 1008 | 1008/1014 (99 %) | 17 diff (98.4 %id) | |||
BX394936 | Neuroblastoma Cot 25-normalized | .a | 34 to 1064 | 1 to 1019 | 1019/1019 (100 %) | 71 diff (93.1 %id) | |||
AL535970 | brain, fetal brain | .b | 1996 to 2847 | 854 to 1 | 854/854 (100 %) | 16 diff (98.2 %id) | |||
AL535971 | brain, fetal brain | .b | 33 to 897 | 1 to 862 | 862/862 (100 %) | 3 diff (99.7 %id) | |||
BX420784 | brain, fetal brain | .a | 33 to 1057 | 1 to 1016 | 1016/1022 (99 %) | 12 diff (98.9 %id) | |||
AL555680 | placenta | .a | 315 to 1249 | 1 to 930 | 930/930 (100 %) | 5 diff (99.5 %id) | |||
AL578125 | placenta | .k | 510 to 1328 | 853 to 32 | 822/960 (85 %) | 3 diff (99.7 %id) | |||
BX344568 | .a | 2002 to 3032 | 1055 to 30 | 1026/1126 (91 %) | 5 diff (99.6 %id) | ||||
BX344569 | .a | 315 to 1347 | 1 to 1026 | 1026/1030 (99 %) | 8 diff (99.3 %id) | ||||
AL554962 | placenta | .d | 14 to 431 | 1 to 418 | 418/418 (100 %) | 2 diff (99.6 %id) | |||
AL577571 | placenta | .d | 1840 to 2268 | 453 to 20 | 434/453 (95 %) | 0 diff (100 %id) | |||
AL556062 | placenta | .a | 14 to 1009 | 1 to 991 | 991/1002 (98 %) | 13 diff (98.8 %id) | |||
AL578416 | placenta | .a | 2015 to 3045 | 1029 to 13 | 1017/1060 (95 %) | 20 diff (98.2 %id) | |||
BX328139 | .a | 290 to 1068 | 1 to 775 | 775/913 (84 %) | 25 diff (97.3 %id) | ||||
BX342331 | .a | 21 to 360 | 1 to 342 | 342/342 (100 %) | 7 diff (98.0 %id) | ||||
CA389947 | eye, RPE/choroid | .a | 1195 to 1890 | 1 to 696 | 696/696 (100 %) | 0 diff (100 %id) | |||
CU445008 | epidermis | .a | 1280 to 1787 | 17 to 522 | 506/535 (94 %) | 9 diff (98.4 %id) | |||
CU449052 | epidermis | .a | 958 to 1607 | 663 to 14 | Submitted on the opposite strand | 650/689 (94 %) | 2 diff (99.8 %id) | ||
CU451613 | epidermis | .a | 958 to 1622 | 664 to 1 | Submitted on the opposite strand | 664/690 (96 %) | 7 diff (99.0 %id) | ||
CU453689 | epidermis | .a | 1243 to 1498 | 256 to 1 | Submitted on the opposite strand | 256/256 (100 %) | 5 diff (98.1 %id) | ||
CU456840 | epidermis | .a | 1731 to 2449 | 723 to 5 | Submitted on the opposite strand | 719/723 (99 %) | 8 diff (98.9 %id) | ||
CV027057 | mixed | .a | 1031 to 1594 | 1 to 564 | 564/566 (99 %) | 1 diff (99.9 %id) | |||
DA476064 | .a | 826 to 1404 | 2 to 580 | capped | 579/579 (100 %) | 1 diff (99.9 %id) | |||
T19147 | .a | 1793 to 2166 | 1 to 378 | 378/383 (98 %) | 10 diff (97.4 %id) | ||||
EC461798 | Prostate | .b | 2592 to 2672 | 1 to 81 | 81/81 (100 %) | 0 diff (100 %id) | |||
EC499862 | Prostate | .b | 2592 to 2672 | 1 to 83 | 83/83 (100 %) | 2 diff (97.6 %id) | |||
EL593485 | epidermis, skin | .i-u | 1377 to 2024 | 21 to 668 | 648/670 (96 %) | 6 diff (99.2 %id) | |||
ES307982 | beard hair, skin | .a | 16 to 112 | 1 to 97 | 97/97 (100 %) | 0 diff (100 %id) | |||
DA514115 | brain | .a | 611 to 1151 | 2 to 542 | capped | 541/541 (100 %) | 1 diff (99.9 %id) | ||
DA530704 | brain | .a | 711 to 1322 | 2 to 613 | capped | 612/612 (100 %) | 0 diff (100 %id) | ||
CD673999 | eye, lens | .i-u | 2786 to 3349 | 11 to 573 | 563/573 (98 %) | 6 diff (99.0 %id) | |||
BP397794 | pancreatic islet | .b | 2452 to 2941 | 1 to 490 | Submitted on the opposite strand | 490/490 (100 %) | 0 diff (100 %id) | ||
BP395119 | pancreatic islet | .b | 2441 to 2943 | 1 to 503 | tiling clone, | Submitted on the opposite strand | 503/506 (99 %) | 1 diff (99.9 %id) | |
BP395564 | pancreatic islet | .b | 2449 to 2943 | 1 to 496 | Submitted on the opposite strand | 496/499 (99 %) | 3 diff (99.4 %id) | ||
BP395793 | pancreatic islet | .b | 2413 to 2918 | 1 to 506 | Submitted on the opposite strand | 506/508 (99 %) | 2 diff (99.7 %id) | ||
DA546888 | .a | 707 to 1186 | 2 to 481 | capped | 480/480 (100 %) | 0 diff (100 %id) | |||
BP237853 | Liver | .a | 966 to 1587 | 1 to 622 | 622/622 (100 %) | 4 diff (99.4 %id) | |||
BP241142 | Liver | .a | 829 to 1386 | 1 to 558 | 558/558 (100 %) | 1 diff (99.9 %id) | |||
DA578601 | .a | 1 to 546 | 2 to 547 | capped | 546/546 (100 %) | 0 diff (100 %id) | |||
R25290 | whole brain | .i-u | 1787 to 2094 | 1 to 307 | 307/309 (99 %) | 6 diff (98.1 %id) | |||
R46641 | whole brain | .i-u | 3217 to 3608 | 415 to 13 | AAA | 403/405 (99 %) | 13 diff (96.8 %id) | ||
T79205 | liver and spleen | .e | 2983 to 3189 | 208 to 1 | tiling clone, | 208/212 (98 %) | 3 diff (98.6 %id) | ||
T79292 | liver and spleen | .e | 715 to 1071 | 1 to 366 | tiling clone, | 366/422 (86 %) | 11 diff (97.4 %id) | ||
T96611 | liver and spleen | .m-u | 415 to 802 | 392 to 1 | tiling clone, | 392/392 (100 %) | 8 diff (98.0 %id) | ||
T96722 | liver and spleen | .m-u | 1 to 373 | 13 to 392 | tiling clone, | 380/397 (95 %) | 22 diff (94.5 %id) | ||
R72604 | breast | .f | 1009 to 1381 | 381 to 1 | tiling clone, | 381/387 (98 %) | 8 diff (98.0 %id) | ||
R72672 | breast | .f | 2 to 471 | 1 to 477 | 477/495 (96 %) | 20 diff (96.0 %id) | |||
H93425 | eye, retina | .a | 1886 to 2146 | 1 to 261 | 261/261 (100 %) | 0 diff (100 %id) | |||
N26458. matches multiple genes | melanocyte | .i-u | 2491 to 2838 | 1 to 342 | also hits gene PHACTR2andLTV1andC6orf94 | 342/347 (98 %) | 7 diff (98.0 %id) | ||
H99348. matches multiple genes | melanocyte | .b | 2592 to 2941 | 356 to 1 | also hits gene ITSN1 | 356/356 (100 %) | 9 diff (97.5 %id) | ||
N23933 | melanocyte | .i-u | 3134 to 3608 | 471 to 1 | 471/471 (100 %) | 3 diff (99.4 %id) | |||
N35280 | melanocyte | .i-u | 2459 to 2928 | 1 to 477 | 477/514 (92 %) | 20 diff (96.2 %id) | |||
W84584 | liver and spleen | .i-u | 2777 to 3191 | 1 to 416 | 416/416 (100 %) | 12 diff (97.2 %id) | |||
W84585 | liver and spleen | .i-u | 3224 to 3608 | 385 to 1 | 385/385 (100 %) | 6 diff (98.5 %id) | |||
AA161045 | Pancreas | .b | 2588 to 2942 | 355 to 1 | 355/355 (100 %) | 7 diff (98.1 %id) | |||
AA195546 | .b | 2620 to 2916 | 298 to 1 | 298/298 (100 %) | 3 diff (99.0 %id) | ||||
AA586332 | ovary, ovary bulk tumor | .b | 2729 to 2941 | 232 to 20 | AAA | 213/213 (100 %) | 0 diff (100 %id) | ||
AA627975 | colon, colon tumor RER+ | .b | 2428 to 2838 | 412 to 1 | 412/412 (100 %) | 2 diff (99.6 %id) | |||
AA627843 | colon, colon tumor RER+ | .l | 342 to 819 | 476 to 1 | tiling clone, | 476/476 (100 %) | 10 diff (97.9 %id) | ||
AA836025 | germinal center B cell | .h | 1 to 363 | 1 to 361 | tiling clone, | 361/361 (100 %) | 7 diff (98.1 %id) | ||
AA911017 | leiomyosarcoma, soft tissue | .b | 2588 to 2943 | 359 to 4 | 356/359 (99 %) | 0 diff (100 %id) | |||
AA992122 | .b | 2480 to 2943 | 463 to 3 | 461/463 (99 %) | 0 diff (100 %id) | ||||
AI075995 | .b | 2452 to 2941 | 509 to 22 | AAA | 488/488 (100 %) | 4 diff (99.2 %id) | |||
AI076914 | B-cell, chronic lymphotic leukemia | .b | 2526 to 2943 | 418 to 1 | 418/418 (100 %) | 0 diff (100 %id) | |||
AI150352 | .o | 1 to 428 | 440 to 13 | exact | tiling clone, AAA | 428/428 (100 %) | 0 diff (100 %id) | ||
AI241522 | liver and spleen | .b | 2540 to 2941 | 400 to 1 | 400/400 (100 %) | 2 diff (99.5 %id) | |||
AI244182 | Kidney | .b | 2679 to 2941 | 264 to 1 | 264/264 (100 %) | 3 diff (98.9 %id) | |||
AI245857 | Kidney | .b | 2593 to 2941 | 349 to 1 | 349/349 (100 %) | 1 diff (99.8 %id) | |||
AI299285 | 2 pooled tumors (clear cell type), Kidney | .b | 2598 to 2943 | 350 to 5 | 346/350 (98 %) | 0 diff (100 %id) | |||
AI362111 | brain, glioblastoma (pooled) | .b | 2526 to 2943 | 419 to 2 | 418/419 (99 %) | 0 diff (100 %id) | |||
AI362684 | anaplastic oligodendroglioma, brain | .b | 2496 to 2943 | 452 to 7 | 446/452 (98 %) | 0 diff (100 %id) | |||
AI369857 | anaplastic oligodendroglioma, brain | .b | 2651 to 2942 | 290 to 1 | 290/376 (77 %) | 1 diff (99.8 %id) | |||
AI364652 | B-cell, chronic lymphotic leukemia | .b | 2762 to 2942 | 181 to 1 | 181/181 (100 %) | 0 diff (100 %id) | |||
AI423752 | brain, glioblastoma (pooled) | .b | 2635 to 2941 | 307 to 1 | 307/307 (100 %) | 0 diff (100 %id) | |||
AI380667 | B-cell, chronic lymphotic leukemia | .b | 2576 to 2943 | 368 to 7 | 362/368 (98 %) | 0 diff (100 %id) | |||
AI392732 | B-cell, chronic lymphotic leukemia | .b | 2526 to 2943 | 412 to 1 | 412/412 (100 %) | 2 diff (99.6 %id) | |||
AI457768 | pooled | .b | 2740 to 2943 | 210 to 7 | 204/210 (97 %) | 0 diff (100 %id) | |||
AI479946 | anaplastic oligodendroglioma, brain | .b | 2472 to 2943 | 471 to 2 | 470/471 (99 %) | 0 diff (100 %id) | |||
AI688945 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .b | 2442 to 2941 | 500 to 1 | 500/500 (100 %) | 0 diff (100 %id) | |||
AI640771 | Kidney | .b | 2546 to 2941 | 395 to 1 | 395/395 (100 %) | 4 diff (99.0 %id) | |||
AI632526 | pooled germ cell tumors | .b | 2472 to 2943 | 476 to 7 | 470/476 (98 %) | 0 diff (100 %id) | |||
AI693905 | carcinoid, lung | .b | 2491 to 2932 | 451 to 12 | AAA | 440/440 (100 %) | 3 diff (99.4 %id) | ||
AI800781 | pooled | .b | 2594 to 2943 | 371 to 22 | 350/371 (94 %) | 0 diff (100 %id) | |||
AI768844 | 2 pooled tumors (clear cell type), Kidney | .b | 2510 to 2943 | 436 to 2 | 435/436 (99 %) | 0 diff (100 %id) | |||
AI858875 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .b | 2796 to 2942 | 145 to 1 | 145/145 (100 %) | 3 diff (98.0 %id) | |||
AI857447 | anaplastic oligodendroglioma, brain | .b | 2645 to 2943 | 300 to 4 | 297/366 (81 %) | 0 diff (100 %id) | |||
AI937631 | anaplastic oligodendroglioma, brain | .j | 243 to 532 | 290 to 1 | 290/290 (100 %) | 0 diff (100 %id) | |||
AI984151 | colon, colonic mucosa from 3 patients with Crohn'sdisease | .b | 2501 to 2943 | 443 to 1 | 443/444 (99 %) | 0 diff (100 %id) | |||
AI971819 | fibrotheoma, ovary | .h | 17 to 342 | 1 to 326 | tiling clone, | Submitted on the opposite strand | 326/326 (100 %) | 1 diff (99.7 %id) | |
AW132049 | poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus | .b | 2672 to 2943 | 272 to 1 | 272/272 (100 %) | 1 diff (99.7 %id) | |||
AW188469 | colon, moderately differentiated adenocarcinoma | .b | 2510 to 2943 | 438 to 4 | 435/438 (99 %) | 0 diff (100 %id) | |||
AW190651 | adenocarcinoma, Pancreas | .b | 2623 to 2943 | 321 to 1 | 321/321 (100 %) | 4 diff (98.8 %id) | |||
AW237791 | Kidney | .b | 2647 to 2941 | 293 to 1 | 293/293 (100 %) | 3 diff (99.0 %id) | |||
AW134544 | .b | 2525 to 2941 | 432 to 18 | AAA | 415/415 (100 %) | 2 diff (99.6 %id) | |||
AW138702 | .b | 2467 to 2941 | 492 to 18 | AAA | 475/475 (100 %) | 0 diff (100 %id) | |||
AW249366 | lung, small cell carcinoma | .a | 868 to 1445 | 1 to 578 | available from MGC, | 578/578 (100 %) | 5 diff (99.2 %id) | ||
BC007214 | Lung, small cell carcinoma | .a | 877 to 3092 | 1 to 2216 | available from MGC, AAA | 2216/2216 (100 %) | 0 diff (100 %id) | ||
AW246346 | lung, small cell carcinoma | .i-u | 680 to 1176 | 6 to 502 | 497/502 (99 %) | 6 diff (98.9 %id) | |||
AW246559 | lung, small cell carcinoma | .i-u | 3233 to 3608 | 386 to 11 | AAA | 376/376 (100 %) | 0 diff (100 %id) | ||
AW340995 | carcinoid, lung | .b | 2740 to 2942 | 205 to 1 | 205/205 (100 %) | 2 diff (99.1 %id) | |||
AW612880 | colon, moderately-differentiated adenocarcinoma | .b | 2468 to 2933 | 464 to 1 | 464/464 (100 %) | 2 diff (99.6 %id) | |||
BQ028794 | Bone, Subchondral Bone | .a | 2434 to 3083 | 668 to 19 | AAA | 650/650 (100 %) | 0 diff (100 %id) | ||
BC000536 | Brain, neuroblastoma | .a | 1535 to 3092 | 1 to 1556 | available from MGC, AAA | 1556/1556 (100 %) | 1 diff (100.0 %id) | ||
BE261441 | brain, neuroblastoma | .a | 1554 to 2218 | 1 to 665 | available from MGC, | 667/721 (92 %) | 22 diff (97.0 %id) | ||
BE856886 | pooled | .j | 1 to 564 | 578 to 16 | T4L P5L R6G K7R M8C ... | tiling clone, AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 563/579 (97 %) | 1 diff (99.9 %id) |
BE857981 | pooled | .b | 2551 to 2943 | 395 to 2 | 394/395 (99 %) | 0 diff (100 %id) | |||
BF062552 | colon, colon tumor, RER+ | .b | 2471 to 2941 | 469 to 1 | 469/469 (100 %) | 1 diff (99.8 %id) | |||
BE273909 | Kidney, renal cell adenocarcinoma | .i-u | 1434 to 2097 | 1 to 669 | 669/692 (96 %) | 21 diff (97.0 %id) | |||
BE255595 | eye, retinoblastoma | .a | 2311 to 2914 | 1 to 602 | 602/682 (88 %) | 13 diff (98.1 %id) | |||
BF475408 | sciatic nerve | .b | 2551 to 2941 | 389 to 1 | 389/389 (100 %) | 2 diff (99.5 %id) | |||
BE536240 | cervix | .a | 1578 to 2287 | 1 to 705 | 705/705 (100 %) | 16 diff (97.8 %id) | |||
BE264619 | lung, small cell carcinoma | .i-u | 703 to 1264 | 1 to 572 | 572/575 (99 %) | 13 diff (97.8 %id) | |||
BE278178 | choriocarcinoma, placenta | .a | 833 to 1457 | 1 to 629 | 629/668 (94 %) | 27 diff (96.0 %id) | |||
BE388574 | endometrium, adenocarcinoma cell line, uterus | .i-u | 1717 to 2221 | 1 to 514 | 514/516 (99 %) | 10 diff (98.1 %id) | |||
BE388357 | endometrium, adenocarcinoma cell line, uterus | .i-u | 1719 to 2388 | 1 to 662 | 662/667 (99 %) | 19 diff (97.2 %id) | |||
BE409891 | choriocarcinoma, placenta | .a | 67 to 764 | 45 to 739 | 695/825 (84 %) | 18 diff (97.9 %id) | |||
BE408524 | choriocarcinoma, placenta | .i-u | 1719 to 2351 | 1 to 633 | 633/634 (99 %) | 1 diff (99.9 %id) | |||
BF436744 | breast, invasive ductal carcinoma, 3 pooled samples | .b | 2461 to 2943 | 481 to 1 | 481/481 (100 %) | 1 diff (99.8 %id) | |||
BF030832 | hypernephroma, Kidney | .i-u | 2500 to 3123 | 1 to 622 | 622/811 (76 %) | 35 diff (95.7 %id) | |||
BE728471 | melanotic melanoma, skin | .a | 36 to 679 | 1 to 636 | 636/995 (63 %) | 12 diff (98.8 %id) | |||
BE872248 | adenocarcinoma, colon | .a | 988 to 1712 | 1 to 737 | 735/740 (99 %) | 29 diff (96.1 %id) | |||
BE875605 | large cell carcinoma, undifferentiated, lung | .a | 2144 to 2824 | 1 to 681 | 681/681 (100 %) | 7 diff (99.0 %id) | |||
BE893810 | melanotic melanoma, skin | .a | 34 to 724 | 1 to 685 | 685/745 (91 %) | 11 diff (98.6 %id) | |||
BF027519 | melanotic melanoma, skin | .i-u | 1692 to 2295 | 32 to 634 | 603/634 (95 %) | 6 diff (99.1 %id) | |||
BE901196 | choriocarcinoma, placenta | .a | 50 to 679 | 1 to 622 | 622/908 (68 %) | 9 diff (99.1 %id) | |||
BE902958 | choriocarcinoma, placenta | .i-u | 2160 to 2965 | 1 to 797 | 797/884 (90 %) | 28 diff (96.9 %id) | |||
BF125459 | melanotic melanoma, skin | .a | 1878 to 2514 | 1 to 630 | 631/845 (74 %) | 20 diff (97.7 %id) | |||
BF237827 | leiomyosarcoma cell line, uterus | .a | 1102 to 1898 | 1 to 790 | 790/869 (90 %) | 33 diff (96.3 %id) | |||
BG236258 | blood, lymphocyte | .b | 2460 to 2943 | 482 to 1 | 482/482 (100 %) | 1 diff (99.8 %id) | |||
BF530402 | anaplastic oligodendroglioma with 1p/19qloss, brain | .b | 2594 to 2941 | 1 to 346 | AAA | 346/346 (100 %) | 1 diff (99.8 %id) | ||
BG107035 | lymph, lymphoma, cell line | .a | 9 to 687 | 1 to 677 | 675/687 (98 %) | 16 diff (97.7 %id) | |||
BG035953 | adenocarcinoma, cell line, Liver | .i-u | 1897 to 2674 | 1 to 775 | 775/888 (87 %) | 22 diff (97.6 %id) | |||
BI850700 | lymph, lymphoma, cell line | .a | 2201 to 2805 | 1 to 608 | 608/608 (100 %) | 7 diff (98.9 %id) | |||
BG120533 | adenocarcinoma, cell line, Liver | .a | 1595 to 2288 | 1 to 690 | 690/741 (93 %) | 6 diff (99.2 %id) | |||
BG250110 | adenocarcinoma, cell line, Liver | .b | 2318 to 2940 | 11 to 631 | AAA | 621/631 (98 %) | 6 diff (99.1 %id) | ||
BG419473 | Kidney, renal cell adenocarcinoma | .i-u | 1414 to 2184 | 1 to 767 | 767/1065 (72 %) | 31 diff (97.1 %id) | |||
BG478125 | melanotic melanoma, skin | .a | 2129 to 2813 | 1 to 685 | 685/685 (100 %) | 1 diff (99.9 %id) | |||
BG473591 | eye, retinoblastoma | .a | 6 to 750 | 1 to 759 | 759/868 (87 %) | 42 diff (95.2 %id) | |||
BG479103 | choriocarcinoma, placenta | .a | 812 to 1628 | 1 to 814 | 814/878 (92 %) | 12 diff (98.7 %id) | |||
BG480602 | choriocarcinoma, placenta | .a | 5 to 512 | 1 to 526 | 526/885 (59 %) | 36 diff (96.0 %id) | |||
BG479581 | choriocarcinoma, placenta | .a | 5 to 805 | 1 to 800 | 800/800 (100 %) | 14 diff (98.3 %id) | |||
BG750091 | eye, normal pigmented retinal epithelium | .a | 686 to 1561 | 1 to 870 | 870/939 (92 %) | 9 diff (99.1 %id) | |||
BG747066 | adenocarcinoma cell line, colon | .a | 895 to 1629 | 1 to 736 | 736/749 (98 %) | 2 diff (99.8 %id) | |||
BG824664 | adenocarcinoma cell line, colon | .a | 944 to 1787 | 1 to 834 | 834/837 (99 %) | 12 diff (98.6 %id) | |||
BG819243 | anaplastic oligodendroglioma with 1p/19qloss, brain | .a | 2323 to 3079 | 1 to 755 | 755/755 (100 %) | 9 diff (98.9 %id) | |||
BI261893 | lymph, lymphoma, cell line | .i-u | 1289 to 2152 | 1 to 863 | W49R P57A P58T E59* | tiling clone, | 863/870 (99 %) | 30 diff (96.6 %id) | |
BI820342 | pooled brain, lung, testis | .a | 2134 to 2932 | 1 to 798 | 798/798 (100 %) | 7 diff (99.2 %id) | |||
BI523938 | pooled lung and spleen | .a | 2430 to 3087 | 1 to 658 | fully sequenced, | 658/658 (100 %) | 6 diff (99.1 %id) | ||
BI524684 | pooled lung and spleen | .a | 2431 to 3012 | 584 to 1 | fully sequenced, | 584/584 (100 %) | 3 diff (99.5 %id) | ||
BM011114 | brain, neuroblastoma, cell line | .i-u | 1132 to 1900 | 1 to 773 | 773/773 (100 %) | 17 diff (97.9 %id) | |||
BM016914 | astrocytoma grade IV, cell line, brain | .a | 1020 to 1850 | 1 to 823 | 823/824 (99 %) | 14 diff (98.4 %id) | |||
BM019401 | astrocytoma grade IV, cell line, brain | .a | 1020 to 1675 | 1 to 661 | 661/986 (67 %) | 18 diff (98.2 %id) | |||
BM020202 | astrocytoma grade IV, cell line, brain | .i-u | 2065 to 2922 | 1 to 860 | 860/968 (88 %) | 20 diff (98.0 %id) | |||
BM048028 | carcinoma, cell line, Prostate | .i-u | 1492 to 2182 | 1 to 695 | 695/695 (100 %) | 17 diff (97.6 %id) | |||
BM045130 | carcinoma, cell line, Prostate | .a | 1020 to 1722 | 1 to 712 | 712/712 (100 %) | 10 diff (98.6 %id) | |||
BM045971 | carcinoma, cell line, Prostate | .i-u | 1492 to 2271 | 1 to 787 | 787/904 (87 %) | 22 diff (97.6 %id) | |||
BM049397 | carcinoma, cell line, Prostate | .i-u | 1492 to 2166 | 1 to 679 | 679/680 (99 %) | 19 diff (97.3 %id) | |||
BM012099 | brain, neuroblastoma, cell line | .a | 648 to 1548 | 1 to 901 | 899/901 (99 %) | 23 diff (97.5 %id) | |||
BM913027 | amelanotic melanoma, cell line, skin | .a | 690 to 1208 | 1 to 519 | 519/1342 (38 %) | 7 diff (99.5 %id) | |||
BM904117 | lymph, lymphoma, cell line | .a | 15 to 851 | 1 to 843 | 843/1062 (79 %) | 11 diff (99.0 %id) | |||
BM472596 | melanotic melanoma, skin | .a | 1614 to 2440 | 2 to 833 | 832/961 (86 %) | 16 diff (98.4 %id) | |||
BM042305 | melanotic melanoma, cell line, skin | .a | 2286 to 2969 | 1 to 684 | 684/684 (100 %) | 4 diff (99.5 %id) | |||
BM904823 | melanotic melanoma, skin | .i-u | 1876 to 2605 | 1 to 743 | 743/953 (77 %) | 17 diff (98.3 %id) | |||
BM468215 | melanotic melanoma, skin | .a | 11 to 681 | 1 to 676 | 676/1034 (65 %) | 12 diff (98.9 %id) | |||
BM475868 | eye, retinoblastoma | .a | 24 to 655 | 1 to 634 | 634/1118 (56 %) | 24 diff (97.9 %id) | |||
BQ072890 | leukocyte | .a | 28 to 671 | 1 to 647 | 647/1165 (55 %) | 15 diff (98.8 %id) | |||
BM926777 | brain | .a | 869 to 1763 | 1 to 901 | 901/1015 (88 %) | 13 diff (98.8 %id) | |||
BQ056481 | lymph, lymphoma, cell line | .i-u | 1292 to 2222 | 1 to 939 | E24* | 939/998 (94 %) | 50 diff (95.0 %id) | ||
BQ018700 | lung, Metastatic Chondrosarcoma | .b | 2394 to 2941 | 566 to 19 | AAA | 548/556 (98 %) | 0 diff (100 %id) | ||
BQ014101 | Chondrosarcoma, Left Pubic Bone | .a | 2397 to 3092 | 714 to 19 | AAA | 696/696 (100 %) | 0 diff (100 %id) | ||
BQ010258 | Chondrosarcoma, Left Pubic Bone | .a | 2426 to 3092 | 684 to 19 | AAA | 666/666 (100 %) | 1 diff (99.9 %id) | ||
BQ002849 | Chondrosarcoma, Left Pelvis | .a | 2385 to 3092 | 725 to 19 | AAA | 707/707 (100 %) | 1 diff (99.9 %id) | ||
BQ016052 | lung, Metastatic Chondrosarcoma | .b | 2288 to 2941 | 670 to 19 | AAA | 652/657 (99 %) | 3 diff (99.6 %id) | ||
BQ061049 | lymph, lymphoma, cell line | .i-u | 1282 to 2119 | 15 to 855 | W49R P57A P58T E59* | 841/1000 (84 %) | 6 diff (99.4 %id) | ||
BQ062177 | lymph, lymphoma, cell line | .a | 1 to 671 | 2 to 678 | 678/1055 (64 %) | 15 diff (98.6 %id) | |||
BQ063038 | lymph, lymphoma, cell line | .i-u | 1289 to 2284 | 1 to 1007 | G13R G17R R27K G30R W49R ... | 1007/1043 (96 %) | 43 diff (95.9 %id) | ||
BQ063108 | lymph, lymphoma, cell line | .i-u | 1292 to 2180 | 1 to 895 | W49R P57A P58T E59* | 895/999 (89 %) | 13 diff (98.7 %id) | ||
BQ063791 | lymph, lymphoma, cell line | .i-u | 1292 to 2172 | 1 to 892 | W49R P57A P58T E59* | 892/1075 (82 %) | 39 diff (96.4 %id) | ||
BQ053440 | blood, natural killer cells, cell line | .a | 906 to 1783 | 20 to 904 | 885/1007 (87 %) | 24 diff (97.7 %id) | |||
BQ422332 | embryonal carcinoma, cell line, testis | .a | 27 to 678 | 1 to 659 | 659/966 (68 %) | 21 diff (97.9 %id) | |||
BQ421832 | large cell carcinoma, lung | .a | 16 to 676 | 19 to 684 | 666/999 (66 %) | 21 diff (97.9 %id) | |||
BQ220499 | embryonal carcinoma, cell line, testis | .a | 2002 to 2881 | 1 to 880 | 880/880 (100 %) | 5 diff (99.5 %id) | |||
BQ214557 | embryonal carcinoma, cell line, testis | .a | 754 to 1358 | 1 to 608 | 608/954 (63 %) | 11 diff (98.9 %id) | |||
BM893835 | Islets of Langerhans, Pancreas | .b | 2795 to 2941 | 164 to 20 | AAA | 145/145 (100 %) | 2 diff (98.7 %id) | ||
BM967138 | Islets of Langerhans, Pancreas | .b | 2306 to 2873 | 1 to 566 | 566/566 (100 %) | 1 diff (99.9 %id) | |||
CK823427 | Islets of Langerhans, Pancreas | .b | 2306 to 2888 | 1 to 581 | 581/581 (100 %) | 1 diff (99.9 %id) | |||
BU154228 | eye, retinoblastoma | .i-u | 148 to 849 | 1 to 713 | 713/901 (79 %) | 20 diff (97.8 %id) | |||
BQ437623 | melanotic melanoma, skin | .a | 503 to 1348 | 1 to 853 | 853/896 (95 %) | 22 diff (97.6 %id) | |||
BQ438271 | leiomyosarcoma, uterus | .a | 13 to 750 | 12 to 759 | 748/900 (83 %) | 27 diff (97.0 %id) | |||
BQ722099 | sympathetic trunk | .a | 1629 to 2404 | 1 to 782 | 782/897 (87 %) | 7 diff (99.3 %id) | |||
BQ717378 | sympathetic trunk | .a | 1168 to 1626 | 91 to 550 | 460/1328 (34 %) | 13 diff (99.1 %id) | |||
BQ880812 | ductal carcinoma, cell line, Pancreas | .a | 1282 to 2098 | 1 to 817 | 817/906 (90 %) | 7 diff (99.3 %id) | |||
BQ675706 | epidermoid carcinoma, cell line, salivary gland | .a | 1587 to 2208 | 1 to 626 | 626/967 (64 %) | 21 diff (97.9 %id) | |||
BQ709252 | Spleen | .e | 1016 to 1756 | 1 to 742 | tiling clone, | 742/911 (81 %) | 23 diff (97.5 %id) | ||
BQ680734 | melanotic melanoma, cell line, skin | .a | 327 to 961 | 1 to 634 | 634/932 (68 %) | 11 diff (98.9 %id) | |||
BQ679380 | melanotic melanoma, cell line, skin | .a | 327 to 1070 | 1 to 748 | 748/987 (75 %) | 12 diff (98.8 %id) | |||
BQ647708 | hepatocellular carcinoma, cell line, Liver | .a | 1659 to 2404 | 1 to 746 | 746/929 (80 %) | 5 diff (99.5 %id) | |||
BQ677264 | melanotic melanoma, cell line, skin | .a | 327 to 1071 | 1 to 747 | 747/923 (80 %) | 12 diff (98.7 %id) | |||
BQ682774 | melanotic melanoma, cell line, skin | .a | 327 to 1163 | 1 to 842 | 842/938 (89 %) | 18 diff (98.1 %id) | |||
BQ642811 | lymph, lymphoma, cell line | .i-u | 1292 to 2168 | 1 to 891 | W49R P57A P58T E59* | 891/920 (96 %) | 36 diff (96.1 %id) | ||
BQ919089 | carcinoma, cell line, Prostate | .i-u | 1494 to 2427 | 1 to 940 | 940/941 (99 %) | 20 diff (97.9 %id) | |||
BQ888366 | epidermoid carcinoma, cell line, lung | .a | 994 to 1874 | 36 to 925 | 890/928 (95 %) | 22 diff (97.7 %id) | |||
BU602881 | mixed (pool of 40 RNAs) | .a | 2090 to 2927 | 1 to 846 | 846/846 (100 %) | 32 diff (96.3 %id) | |||
BC110852 | Uterus, leiomyosarcoma | .d | 175 to 2317 | 1 to 2149 | exact | tiling clone, AAA | 2149/2149 (100 %) | 5 diff (99.8 %id) | |
BU507784 | leiomyosarcoma, uterus | .d | 177 to 1010 | 1 to 840 | 840/875 (96 %) | 8 diff (99.1 %id) | |||
BU509412 | leiomyosarcoma, uterus | .a | 859 to 1703 | 1 to 851 | 851/920 (92 %) | 17 diff (98.2 %id) | |||
BU543598 | carcinoma, cell line, Prostate | .i-u | 1494 to 2335 | 1 to 848 | 848/859 (98 %) | 16 diff (98.2 %id) | |||
BU845675 | ovary, teratocarcinoma, cell line | .a | 18 to 861 | 1 to 855 | 855/929 (92 %) | 26 diff (97.3 %id) | |||
BU846407 | ovary, teratocarcinoma, cell line | .a | 18 to 851 | 1 to 836 | 836/919 (90 %) | 9 diff (99.1 %id) | |||
BU557063 | ovary, teratocarcinoma, cell line | .a | 18 to 851 | 1 to 837 | 837/898 (93 %) | 7 diff (99.3 %id) | |||
CX165078 | human embryonic stem cells differentiated toan early endodermal cell type | .a | 1629 to 2437 | 1 to 809 | 809/809 (100 %) | 0 diff (100 %id) | |||
CX872851 | embryonic stem | .a | 1073 to 1879 | 1 to 807 | 807/807 (100 %) | 0 diff (100 %id) | |||
DR760800 | embryonic stem | .a | 1533 to 2334 | 1 to 801 | 801/801 (100 %) | 1 diff (99.9 %id) | |||
CD245412 | White Matter | .a | 14 to 851 | 1 to 842 | 842/872 (96 %) | 7 diff (99.2 %id) | |||
CF272267 | Brain glioblastoma | .a | 1222 to 2096 | 1 to 880 | 880/1021 (86 %) | 16 diff (98.5 %id) | |||
CO249883 | Chondrosarcoma Lung Metastasis cell lines, lung | .a | 246 to 849 | 8 to 610 | 603/733 (82 %) | 11 diff (98.5 %id) | |||
CO246931 | Chondrosarcoma Lung Metastasis cell lines, lung | .i-u | 792 to 1308 | 49 to 569 | 521/723 (72 %) | 54 diff (92.6 %id) | |||
CO247732 | Chondrosarcoma Lung Metastasis cell lines, lung | .a | 697 to 1355 | 1 to 656 | 656/751 (87 %) | 13 diff (98.3 %id) | |||
CO249888 | Chondrosarcoma Lung Metastasis cell lines, lung | .a | 741 to 1481 | 49 to 789 | 743/789 (94 %) | 8 diff (99.0 %id) | |||
CO248558 | Chondrosarcoma Lung Metastasis cell lines, lung | .a | 41 to 677 | 1 to 635 | 635/814 (78 %) | 9 diff (98.9 %id) | |||
CO248689 | Chondrosarcoma Lung Metastasis cell lines, lung | .a | 1 to 679 | 12 to 687 | 680/814 (83 %) | 10 diff (98.8 %id) | |||
BC110072 | PCR rescued clones | .g | 1 to 654 | 14 to 667 | exact | tiling clone, | 654/689 (94 %) | 7 diff (99.0 %id) | |
TI_57198947 | .a | 2127 to 2932 | 24 to 828 | 805/828 (97 %) | 11 diff (98.7 %id) | ||||
TI_44159005 | .b | 2288 to 2936 | 76 to 724 | fully sequenced, | 649/724 (89 %) | 7 diff (99.1 %id) | |||
TI_44159006 | .b | 2337 to 2861 | 527 to 1 | fully sequenced, | 527/527 (100 %) | 3 diff (99.5 %id) | |||
TI_59380007 | .i-u | 1106 to 1900 | 72 to 870 | 799/870 (91 %) | 6 diff (99.4 %id) | ||||
TI_59381297 | .a | 649 to 1548 | 99 to 998 | 898/900 (99 %) | 22 diff (97.6 %id) | ||||
TI_59387153 | .a | 1021 to 1850 | 46 to 867 | 822/823 (99 %) | 13 diff (98.5 %id) | ||||
TI_59390082 | .a | 1021 to 1675 | 98 to 757 | 660/985 (67 %) | 17 diff (98.3 %id) | ||||
TI_59390983 | .i-u | 2066 to 2922 | 102 to 960 | 859/967 (88 %) | 20 diff (98.0 %id) | ||||
DA621381 | Kidney | .a | 999 to 1563 | 2 to 566 | capped | 565/565 (100 %) | 0 diff (100 %id) | ||
DA633510 | Kidney | .a | 940 to 1521 | 2 to 584 | capped | 583/583 (100 %) | 1 diff (99.9 %id) | ||
BP304719 | .a | 2088 to 2591 | 81 to 583 | 507/583 (86 %) | 10 diff (98.3 %id) | ||||
BP305638 | .a | 991 to 1569 | 1 to 578 | 578/630 (91 %) | 20 diff (96.9 %id) | ||||
NM_018052.3 | .a | 1 to 3092 | 3 to 3094 | exact | RefSeq, AAA | 3094/3094 (100 %) | 0 diff (100 %id) | ||
DA695948 | .a | 826 to 1377 | 2 to 553 | capped | 552/552 (100 %) | 2 diff (99.7 %id) | |||
AU123413 | .a | 1541 to 2211 | 2 to 677 | capped | 676/737 (91 %) | 16 diff (97.9 %id) | |||
DA740147 | .d | -10 to 417 | 2 to 431 | tiling clone, capped | 430/430 (100 %) | 2 diff (99.6 %id) | |||
DB324650 | .d | 1810 to 2317 | 508 to 1 | tiling clone, | 508/508 (100 %) | 0 diff (100 %id) | |||
DC370978 | .b | 4 to 575 | 1 to 573 | 573/573 (100 %) | 2 diff (99.7 %id) | ||||
DC374161 | brain | .b | 1 to 565 | 3 to 568 | 568/569 (99 %) | 3 diff (99.5 %id) | |||
DC374813 | brain | .b | 1 to 572 | 3 to 574 | 574/574 (100 %) | 0 diff (100 %id) | |||
DA784896 | brain | .a | 1 to 458 | 2 to 459 | capped | 458/458 (100 %) | 3 diff (99.4 %id) | ||
CD723405 | eye, lacrimal gland | .a | 2286 to 2898 | 7 to 627 | 630/627 (100 %) | 56 diff (91.1 %id) | |||
CR997082 | T-Lymphocytes | .a | 10 to 830 | 1 to 821 | 821/827 (99 %) | 1 diff (99.9 %id) | |||
CR997932 | T-Lymphocytes | .i-u | 2454 to 3199 | 1 to 753 | 753/753 (100 %) | 7 diff (99.1 %id) | |||
BM797983 | Ascites, stomach | .n | 527 to 748 | 54 to 275 | 222/275 (80 %) | 9 diff (96.8 %id) | |||
BQ082405 | Ascites, stomach | .k | 1 to 576 | 1 to 576 | tiling clone, | 576/576 (100 %) | 0 diff (100 %id) | ||
CB105697 | Ascites, stomach | .i-u | 2009 to 2491 | 1 to 483 | 483/483 (100 %) | 0 diff (100 %id) | |||
TI_1948094844 | .a | 1027 to 1734 | 124 to 834 | 711/1392 (51 %) | 27 diff (98.1 %id) | ||||
TI_1948094845 | .a | 1915 to 2604 | 812 to 124 | 689/1304 (52 %) | 14 diff (99.0 %id) | ||||
TI_1948094982 | .a | 1027 to 1516 | 125 to 614 | 490/1394 (35 %) | 55 diff (96.1 %id) | ||||
TI_1948094983 | .a | 1924 to 2604 | 808 to 124 | 685/1256 (54 %) | 28 diff (97.8 %id) | ||||
TI_1948095146 | .a | 1020 to 1781 | 134 to 898 | 765/1323 (57 %) | 22 diff (98.4 %id) | ||||
TI_1948095147 | .a | 1913 to 2607 | 816 to 120 | 697/1357 (51 %) | 19 diff (98.6 %id) | ||||
TI_1948095302 | .a | 1019 to 1770 | 113 to 871 | 759/1422 (53 %) | 40 diff (97.2 %id) | ||||
TI_1948095303 | .a | 2007 to 2604 | 725 to 123 | 603/1313 (45 %) | 8 diff (99.4 %id) | ||||
DA951011 | Spleen | .a | 711 to 1272 | 2 to 563 | capped | 562/562 (100 %) | 1 diff (99.9 %id) | ||
T15881 | .b | 2730 to 2941 | 213 to 1 | 213/235 (90 %) | 4 diff (98.3 %id) | ||||
DR001846 | fetal brain | .a | 1 to 646 | 14 to 658 | 650/658 (98 %) | 8 diff (98.8 %id) | |||
DN997436 | breast cancer, Mammary gland (cancer tissue) | .a | 1143 to 1699 | 3 to 559 | 557/559 (99 %) | 6 diff (99.0 %id) | |||
BM146195 | leukopheresis | .a | 1 to 270 | 4 to 273 | 273/273 (100 %) | 13 diff (95.3 %id) | |||
BM145951 | leukopheresis | .b | 2679 to 2916 | 255 to 17 | AAA | 239/239 (100 %) | 11 diff (95.4 %id) | ||
BM148120 | leukopheresis | .a | 1 to 494 | 4 to 497 | 497/498 (99 %) | 7 diff (98.6 %id) | |||
BM148245 | leukopheresis | .a | 3 to 483 | 1 to 481 | 481/481 (100 %) | 3 diff (99.4 %id) | |||
BM152289 | leukopheresis | .a | 3 to 176 | 1 to 174 | 174/174 (100 %) | 3 diff (98.3 %id) | |||
DB044148 | testis | .a | 559 to 1139 | 2 to 586 | capped | 583/585 (99 %) | 7 diff (98.9 %id) | ||
DB056722 | testis | .c | 1 to 543 | 2 to 544 | tiling clone, capped | 543/543 (100 %) | 1 diff (99.9 %id) | ||
DB083247 | testis | .n | 1 to 547 | 2 to 548 | capped | 547/547 (100 %) | 0 diff (100 %id) | ||
DC408639 | thymus | .b | 1 to 541 | 3 to 545 | 545/545 (100 %) | 2 diff (99.7 %id) | |||
DB162397 | thymus | .i-u | 1 to 582 | 2 to 583 | capped | 582/582 (100 %) | 1 diff (99.9 %id) | ||
DB346947 | thymus | .i-u | 3090 to 3608 | 518 to 1 | 518/518 (100 %) | 2 diff (99.7 %id) | |||
TI_154034826 | .a | 2131 to 3092 | 1032 to 84 | AAA | 949/988 (96 %) | 27 diff (97.3 %id) | |||
TI_154056382 | .a | 2282 to 3092 | 896 to 94 | AAA | 803/996 (80 %) | 16 diff (98.4 %id) | |||
TI_154100187 | .i-u | 2915 to 3608 | 786 to 93 | AAA | 694/695 (99 %) | 14 diff (98.0 %id) | |||
TI_154102568 | .a | 2289 to 3092 | 882 to 82 | AAA | 801/804 (99 %) | 8 diff (99.1 %id) | |||
TI_154117184 | .a | 2383 to 3092 | 804 to 93 | AAA | 712/712 (100 %) | 9 diff (98.8 %id) | |||
TI_154129635 | .a | 2344 to 3092 | 836 to 92 | AAA | 745/982 (75 %) | 5 diff (99.5 %id) | |||
TI_154185460 | .a | 1708 to 2599 | 121 to 1004 | 884/1002 (88 %) | 26 diff (97.5 %id) | ||||
TI_154195911 | .c | 539 to 1346 | 81 to 878 | tiling clone, | 798/1011 (78 %) | 20 diff (98.1 %id) | |||
TI_154196335 | .a | 14 to 826 | 18 to 827 | 810/1081 (74 %) | 36 diff (96.7 %id) | ||||
TI_154197967 | .a | 16 to 923 | 106 to 1011 | 906/1021 (88 %) | 34 diff (96.7 %id) | ||||
TI_227713099 | .a | 2123 to 3092 | 1047 to 91 | AAA | 957/1028 (93 %) | 15 diff (98.6 %id) | |||
BP368222 | thymus | .a | 2015 to 2468 | 128 to 581 | 454/581 (78 %) | 2 diff (99.7 %id) | |||
DB205022 | trachea | .h | 143 to 715 | 2 to 574 | capped | 573/573 (100 %) | 1 diff (99.9 %id) | ||
DB348560 | trachea | .h | 1669 to 2213 | 544 to 1 | tiling clone, | 544/546 (99 %) | 3 diff (99.5 %id) | ||
U25801 | .l | 1 to 807 | 1 to 807 | A14P L20P Q128H H129D F155L | tiling clone, | 807/808 (99 %) | 7 diff (99.2 %id) | ||
BQ022977 | placenta | .b | 2660 to 2932 | 289 to 19 | AAA | 271/271 (100 %) | 2 diff (99.3 %id) | ||
BQ023947 | placenta | .b | 2469 to 2941 | 491 to 19 | AAA | 473/473 (100 %) | 3 diff (99.4 %id) | ||
CA503031 | Human Lung Epithelial cells, lung | .b | 2355 to 2941 | 604 to 19 | AAA | 586/587 (99 %) | 6 diff (99.0 %id) | ||
BM716155 | eye, RPE and Choroid | .i-u | 1748 to 2444 | 1 to 697 | 697/697 (100 %) | 0 diff (100 %id) | |||
BU732158 | eye, RPE and Choroid | .i-u | 2957 to 3608 | 670 to 19 | AAA | 652/652 (100 %) | 0 diff (100 %id) | ||
BM672657 | eye, eye anterior segment | .a | 2773 to 3092 | 338 to 19 | AAA | 320/320 (100 %) | 1 diff (99.7 %id) | ||
BM687713 | eye, eye anterior segment | .a | 1916 to 2377 | 1 to 468 | 475/468 (101 %) | 10 diff (97.9 %id) | |||
BM712224 | eye, lens | .k | 518 to 920 | 1 to 403 | tiling clone, fully sequenced, | 403/403 (100 %) | 0 diff (100 %id) | ||
BU737693 | eye, lens | .k | 890 to 1388 | 517 to 19 | tiling clone, fully sequenced, AAA | 499/499 (100 %) | 0 diff (100 %id) | ||
CA441225 | Fibrosarcoma | .b | 2372 to 2941 | 588 to 19 | AAA | 570/570 (100 %) | 0 diff (100 %id) | ||
CA443836 | Fibrosarcoma | .a | 2397 to 3092 | 714 to 19 | AAA | 696/696 (100 %) | 0 diff (100 %id) | ||
CN479513 | Chondrosarcoma, Left Pubic Bone | .b | 2300 to 2941 | 659 to 19 | AAA | 641/647 (99 %) | 2 diff (99.7 %id) | ||
BQ445932 | Knee, Osteoarthritic Cartilage | .b | 2288 to 2941 | 670 to 19 | AAA | 652/657 (99 %) | 4 diff (99.4 %id) | ||
CA418859 | Chondrosarcoma Grade II, Left Pelvis | .b | 2302 to 2941 | 657 to 19 | AAA | 639/639 (100 %) | 2 diff (99.7 %id) | ||
BQ576264 | Chondrosarcoma Grade II, Left Pelvis | .b | 2348 to 2941 | 612 to 19 | AAA | 594/594 (100 %) | 1 diff (99.9 %id) | ||
CA749062 | cell lines, Chondrosarcoma | .b | 2361 to 2941 | 599 to 19 | AAA | 581/581 (100 %) | 1 diff (99.9 %id) | ||
CA307115 | Alveolar Macrophage, lung | .a | 2409 to 3092 | 702 to 19 | AAA | 684/684 (100 %) | 1 diff (99.9 %id) | ||
CA307130 | Alveolar Macrophage, lung | .a | 2357 to 3092 | 754 to 19 | AAA | 736/736 (100 %) | 1 diff (99.9 %id) | ||
CD367442 | Alveolar Macrophage, lung | .a | 2334 to 3092 | 774 to 19 | AAA | 756/756 (100 %) | 3 diff (99.7 %id) | ||
CB528557 | Aveolar Macrophage, lung | .a | 2397 to 3092 | 714 to 19 | AAA | 696/696 (100 %) | 0 diff (100 %id) | ||
TI_151769561 | .i-u | 1748 to 2307 | 109 to 673 | 565/888 (63 %) | 13 diff (98.6 %id) | ||||
DB257450 | uterus | .a | 1039 to 1618 | 2 to 581 | capped | 580/580 (100 %) | 1 diff (99.9 %id) | ||
AK297564 | brain | .a | 1168 to 1626 | 91 to 550 | Suspected internal deletion, suspected internal deletion, this clone was ignored | 460/1328 (34 %) | 13 diff (99.1 %id) | ||
DC353146 | brain | .a | 1282 to 2098 | 1 to 817 | Suspected internal deletion, this clone was ignored | 817/906 (90 %) | 7 diff (99.3 %id) | ||
BP395303 | pancreatic islet | .a | 1282 to 2098 | 1 to 817 | Submitted on the opposite strand, submitted on the opposite strand | 817/906 (90 %) | 7 diff (99.3 %id) | ||
AI040315 | senescent fibroblast | .a | 1587 to 2208 | 1 to 626 | Suspected internal deletion, this clone was ignored | 626/967 (64 %) | 21 diff (97.9 %id) | ||
AI857446 | anaplastic oligodendroglioma, brain | .a | 1587 to 2208 | 1 to 626 | Suspected internal deletion, this clone was ignored | 626/967 (64 %) | 21 diff (97.9 %id) | ||
AI884664 | anaplastic oligodendroglioma, brain | .e | 1016 to 1756 | 1 to 742 | tiling clone, | Suspected internal deletion, this clone was ignored | 742/911 (81 %) | 23 diff (97.5 %id) | |
AI936754 | anaplastic oligodendroglioma, brain | .a | 327 to 961 | 1 to 634 | Suspected internal deletion, this clone was ignored | 634/932 (68 %) | 11 diff (98.9 %id) | ||
DA773737 | brain | .a | 327 to 961 | 1 to 634 | capped | Suspected internal deletion, this clone was ignored | 634/932 (68 %) | 11 diff (98.9 %id) | |
BM147550 | leukopheresis | .a | 327 to 1070 | 1 to 748 | 748/987 (75 %) | 12 diff (98.8 %id) | |||
BP369484 | testis | .a | 327 to 1070 | 1 to 748 | This clone was ignored | 748/987 (75 %) | 12 diff (98.8 %id) | ||
BM664299 | eye, lens | .a | 1659 to 2404 | 1 to 746 | fully sequenced, AAA | Suspected internal deletion, this clone was ignored | 746/929 (80 %) | 5 diff (99.5 %id) | |
BM706439 | eye, lens | .a | 1659 to 2404 | 1 to 746 | fully sequenced, | Suspected internal deletion, this clone was ignored | 746/929 (80 %) | 5 diff (99.5 %id) | |
CA425376 | Bone, Subchondral Bone | .a | 327 to 1071 | 1 to 747 | AAA | This clone was ignored | 747/923 (80 %) | 12 diff (98.7 %id) | |
DB293111 | .a | 327 to 1071 | 1 to 747 | capped | This clone was ignored | 747/923 (80 %) | 12 diff (98.7 %id) | ||
DB383050 | .a | 327 to 1163 | 1 to 842 | This clone was ignored | 842/938 (89 %) | 18 diff (98.1 %id) | |||
BQ682774 | melanotic melanoma, cell line, skin | .a | 327 to 1163 | 1 to 842 | 842/938 (89 %) | 18 diff (98.1 %id) | |||
BQ642811 | lymph, lymphoma, cell line | .i-u | 1292 to 2168 | 1 to 891 | W49R P57A P58T E59* | 891/920 (96 %) | 36 diff (96.1 %id) | ||
BQ642811 | lymph, lymphoma, cell line | .i-u | 1292 to 2168 | 1 to 891 | W49R P57A P58T E59* | 891/920 (96 %) | 36 diff (96.1 %id) | ||
BQ919089 | carcinoma, cell line, Prostate | .i-u | 1494 to 2427 | 1 to 940 | 940/941 (99 %) | 20 diff (97.9 %id) | |||
BQ919089 | carcinoma, cell line, Prostate | .i-u | 1494 to 2427 | 1 to 940 | 940/941 (99 %) | 20 diff (97.9 %id) | |||
BQ888366 | epidermoid carcinoma, cell line, lung | .a | 994 to 1874 | 36 to 925 | 890/928 (95 %) | 22 diff (97.7 %id) | |||
BQ888366 | epidermoid carcinoma, cell line, lung | .a | 994 to 1874 | 36 to 925 | 890/928 (95 %) | 22 diff (97.7 %id) | |||
BU602881 | mixed (pool of 40 RNAs) | .a | 2090 to 2927 | 1 to 846 | 846/846 (100 %) | 32 diff (96.3 %id) | |||
BC110852 | Uterus, leiomyosarcoma | .d | 175 to 2317 | 1 to 2149 | exact | tiling clone, AAA | 2149/2149 (100 %) | 5 diff (99.8 %id) | |
BU507784 | leiomyosarcoma, uterus | .d | 177 to 1010 | 1 to 840 | 840/875 (96 %) | 8 diff (99.1 %id) | |||
BU507784 | leiomyosarcoma, uterus | .d | 177 to 1010 | 1 to 840 | 840/875 (96 %) | 8 diff (99.1 %id) | |||
BU509412 | leiomyosarcoma, uterus | .a | 859 to 1703 | 1 to 851 | 851/920 (92 %) | 17 diff (98.2 %id) | |||
BU509412 | leiomyosarcoma, uterus | .a | 859 to 1703 | 1 to 851 | 851/920 (92 %) | 17 diff (98.2 %id) | |||
BU543598 | carcinoma, cell line, Prostate | .i-u | 1494 to 2335 | 1 to 848 | 848/859 (98 %) | 16 diff (98.2 %id) | |||
BU543598 | carcinoma, cell line, Prostate | .i-u | 1494 to 2335 | 1 to 848 | 848/859 (98 %) | 16 diff (98.2 %id) | |||
BU845675 | ovary, teratocarcinoma, cell line | .a | 18 to 861 | 1 to 855 | 855/929 (92 %) | 26 diff (97.3 %id) | |||
BU845675 | ovary, teratocarcinoma, cell line | .a | 18 to 861 | 1 to 855 | 855/929 (92 %) | 26 diff (97.3 %id) | |||
BU846407 | ovary, teratocarcinoma, cell line | .a | 18 to 851 | 1 to 836 | 836/919 (90 %) | 9 diff (99.1 %id) | |||
BU846407 | ovary, teratocarcinoma, cell line | .a | 18 to 851 | 1 to 836 | 836/919 (90 %) | 9 diff (99.1 %id) | |||
BU557063 | ovary, teratocarcinoma, cell line | .a | 18 to 851 | 1 to 837 | 837/898 (93 %) | 7 diff (99.3 %id) | |||
BU557063 | ovary, teratocarcinoma, cell line | .a | 18 to 851 | 1 to 837 | 837/898 (93 %) | 7 diff (99.3 %id) | |||
CX165078 | human embryonic stem cells differentiated toan early endodermal cell type | .a | 1629 to 2437 | 1 to 809 | 809/809 (100 %) | 0 diff (100 %id) | |||
CX872851 | embryonic stem | .a | 1073 to 1879 | 1 to 807 | 807/807 (100 %) | 0 diff (100 %id) | |||
DR760800 | embryonic stem | .a | 1533 to 2334 | 1 to 801 | 801/801 (100 %) | 1 diff (99.9 %id) | |||
CD245412 | White Matter | .a | 14 to 851 | 1 to 842 | 842/872 (96 %) | 7 diff (99.2 %id) | |||
CF272267 | Brain glioblastoma | .a | 1222 to 2096 | 1 to 880 | 880/1021 (86 %) | 16 diff (98.5 %id) | |||
CO249883 | Chondrosarcoma Lung Metastasis cell lines, lung | .a | 246 to 849 | 8 to 610 | 603/733 (82 %) | 11 diff (98.5 %id) | |||
CO249883 | Chondrosarcoma Lung Metastasis cell lines, lung | .a | 246 to 849 | 8 to 610 | 603/733 (82 %) | 11 diff (98.5 %id) | |||
CO246931 | Chondrosarcoma Lung Metastasis cell lines, lung | .i-u | 792 to 1308 | 49 to 569 | 521/723 (72 %) | 54 diff (92.6 %id) | |||
CO246931 | Chondrosarcoma Lung Metastasis cell lines, lung | .i-u | 792 to 1308 | 49 to 569 | 521/723 (72 %) | 54 diff (92.6 %id) | |||
CO247732 | Chondrosarcoma Lung Metastasis cell lines, lung | .a | 697 to 1355 | 1 to 656 | 656/751 (87 %) | 13 diff (98.3 %id) | |||
CO247732 | Chondrosarcoma Lung Metastasis cell lines, lung | .a | 697 to 1355 | 1 to 656 | 656/751 (87 %) | 13 diff (98.3 %id) | |||
CO249888 | Chondrosarcoma Lung Metastasis cell lines, lung | .a | 741 to 1481 | 49 to 789 | 743/789 (94 %) | 8 diff (99.0 %id) | |||
CO249888 | Chondrosarcoma Lung Metastasis cell lines, lung | .a | 741 to 1481 | 49 to 789 | 743/789 (94 %) | 8 diff (99.0 %id) | |||
CO248558 | Chondrosarcoma Lung Metastasis cell lines, lung | .a | 41 to 677 | 1 to 635 | 635/814 (78 %) | 9 diff (98.9 %id) | |||
CO248558 | Chondrosarcoma Lung Metastasis cell lines, lung | .a | 41 to 677 | 1 to 635 | 635/814 (78 %) | 9 diff (98.9 %id) | |||
CO248689 | Chondrosarcoma Lung Metastasis cell lines, lung | .a | 1 to 679 | 12 to 687 | 680/814 (83 %) | 10 diff (98.8 %id) | |||
CO248689 | Chondrosarcoma Lung Metastasis cell lines, lung | .a | 1 to 679 | 12 to 687 | 680/814 (83 %) | 10 diff (98.8 %id) | |||
BC110072 | PCR rescued clones | .g | 1 to 654 | 14 to 667 | exact | tiling clone, | 654/689 (94 %) | 7 diff (99.0 %id) | |
TI_57198947 | .a | 2127 to 2932 | 24 to 828 | 805/828 (97 %) | 11 diff (98.7 %id) | ||||
TI_44159005 | .b | 2288 to 2936 | 76 to 724 | fully sequenced, | 649/724 (89 %) | 7 diff (99.1 %id) | |||
TI_44159006 | .b | 2337 to 2861 | 527 to 1 | fully sequenced, | 527/527 (100 %) | 3 diff (99.5 %id) | |||
TI_59380007 | .i-u | 1106 to 1900 | 72 to 870 | 799/870 (91 %) | 6 diff (99.4 %id) | ||||
TI_59381297 | .a | 649 to 1548 | 99 to 998 | 898/900 (99 %) | 22 diff (97.6 %id) | ||||
TI_59387153 | .a | 1021 to 1850 | 46 to 867 | 822/823 (99 %) | 13 diff (98.5 %id) | ||||
TI_59390082 | .a | 1021 to 1675 | 98 to 757 | 660/985 (67 %) | 17 diff (98.3 %id) | ||||
TI_59390983 | .i-u | 2066 to 2922 | 102 to 960 | 859/967 (88 %) | 20 diff (98.0 %id) | ||||
DA621381 | Kidney | .a | 999 to 1563 | 2 to 566 | capped | 565/565 (100 %) | 0 diff (100 %id) | ||
DA633510 | Kidney | .a | 940 to 1521 | 2 to 584 | capped | 583/583 (100 %) | 1 diff (99.9 %id) | ||
BP304719 | .a | 2088 to 2591 | 81 to 583 | 507/583 (86 %) | 10 diff (98.3 %id) | ||||
BP305638 | .a | 991 to 1569 | 1 to 578 | 578/630 (91 %) | 20 diff (96.9 %id) | ||||
NM_018052.3 | .a | 1 to 3092 | 3 to 3094 | exact | RefSeq, AAA | 3094/3094 (100 %) | 0 diff (100 %id) | ||
DA695948 | .a | 826 to 1377 | 2 to 553 | capped | 552/552 (100 %) | 2 diff (99.7 %id) | |||
AU123413 | .a | 1541 to 2211 | 2 to 677 | capped | 676/737 (91 %) | 16 diff (97.9 %id) | |||
DA740147 | .d | -10 to 417 | 2 to 431 | tiling clone, capped | 430/430 (100 %) | 2 diff (99.6 %id) | |||
DB324650 | .d | 1810 to 2317 | 508 to 1 | tiling clone, | 508/508 (100 %) | 0 diff (100 %id) | |||
DC370978 | .b | 4 to 575 | 1 to 573 | 573/573 (100 %) | 2 diff (99.7 %id) | ||||
DC374161 | brain | .b | 1 to 565 | 3 to 568 | 568/569 (99 %) | 3 diff (99.5 %id) | |||
DC374813 | brain | .b | 1 to 572 | 3 to 574 | 574/574 (100 %) | 0 diff (100 %id) | |||
DA784896 | brain | .a | 1 to 458 | 2 to 459 | capped | 458/458 (100 %) | 3 diff (99.4 %id) | ||
CD723405 | eye, lacrimal gland | .a | 2286 to 2898 | 7 to 627 | 630/627 (100 %) | 56 diff (91.1 %id) | |||
CD723405 | eye, lacrimal gland | .a | 2286 to 2898 | 7 to 627 | 630/627 (100 %) | 56 diff (91.1 %id) | |||
CR997082 | T-Lymphocytes | .a | 10 to 830 | 1 to 821 | 821/827 (99 %) | 1 diff (99.9 %id) | |||
CR997932 | T-Lymphocytes | .i-u | 2454 to 3199 | 1 to 753 | 753/753 (100 %) | 7 diff (99.1 %id) | |||
BM797983 | Ascites, stomach | .n | 527 to 748 | 54 to 275 | 222/275 (80 %) | 9 diff (96.8 %id) | |||
BM797983 | Ascites, stomach | .n | 527 to 748 | 54 to 275 | 222/275 (80 %) | 9 diff (96.8 %id) | |||
BQ082405 | Ascites, stomach | .k | 1 to 576 | 1 to 576 | tiling clone, | 576/576 (100 %) | 0 diff (100 %id) | ||
BQ082405 | Ascites, stomach | .k | 1 to 576 | 1 to 576 | tiling clone, | 576/576 (100 %) | 0 diff (100 %id) | ||
CB105697 | Ascites, stomach | .i-u | 2009 to 2491 | 1 to 483 | 483/483 (100 %) | 0 diff (100 %id) | |||
CB105697 | Ascites, stomach | .i-u | 2009 to 2491 | 1 to 483 | 483/483 (100 %) | 0 diff (100 %id) | |||
TI_1948094844 | .a | 1027 to 1734 | 124 to 834 | 711/1392 (51 %) | 27 diff (98.1 %id) | ||||
TI_1948094845 | .a | 1915 to 2604 | 812 to 124 | 689/1304 (52 %) | 14 diff (99.0 %id) | ||||
TI_1948094982 | .a | 1027 to 1516 | 125 to 614 | 490/1394 (35 %) | 55 diff (96.1 %id) | ||||
TI_1948094983 | .a | 1924 to 2604 | 808 to 124 | 685/1256 (54 %) | 28 diff (97.8 %id) | ||||
TI_1948095146 | .a | 1020 to 1781 | 134 to 898 | 765/1323 (57 %) | 22 diff (98.4 %id) | ||||
TI_1948095147 | .a | 1913 to 2607 | 816 to 120 | 697/1357 (51 %) | 19 diff (98.6 %id) | ||||
TI_1948095302 | .a | 1019 to 1770 | 113 to 871 | 759/1422 (53 %) | 40 diff (97.2 %id) | ||||
TI_1948095303 | .a | 2007 to 2604 | 725 to 123 | 603/1313 (45 %) | 8 diff (99.4 %id) | ||||
DA951011 | Spleen | .a | 711 to 1272 | 2 to 563 | capped | 562/562 (100 %) | 1 diff (99.9 %id) | ||
T15881 | .b | 2730 to 2941 | 213 to 1 | 213/235 (90 %) | 4 diff (98.3 %id) | ||||
DR001846 | fetal brain | .a | 1 to 646 | 14 to 658 | 650/658 (98 %) | 8 diff (98.8 %id) | |||
DN997436 | breast cancer, Mammary gland (cancer tissue) | .a | 1143 to 1699 | 3 to 559 | 557/559 (99 %) | 6 diff (99.0 %id) | |||
DN997436 | breast cancer, Mammary gland (cancer tissue) | .a | 1143 to 1699 | 3 to 559 | 557/559 (99 %) | 6 diff (99.0 %id) | |||
BM146195 | leukopheresis | .a | 1 to 270 | 4 to 273 | 273/273 (100 %) | 13 diff (95.3 %id) | |||
BM145951 | leukopheresis | .b | 2679 to 2916 | 255 to 17 | AAA | 239/239 (100 %) | 11 diff (95.4 %id) | ||
BM148120 | leukopheresis | .a | 1 to 494 | 4 to 497 | 497/498 (99 %) | 7 diff (98.6 %id) | |||
BM148245 | leukopheresis | .a | 3 to 483 | 1 to 481 | 481/481 (100 %) | 3 diff (99.4 %id) | |||
BM152289 | leukopheresis | .a | 3 to 176 | 1 to 174 | 174/174 (100 %) | 3 diff (98.3 %id) | |||
DB044148 | testis | .a | 559 to 1139 | 2 to 586 | capped | 583/585 (99 %) | 7 diff (98.9 %id) | ||
DB056722 | testis | .c | 1 to 543 | 2 to 544 | tiling clone, capped | 543/543 (100 %) | 1 diff (99.9 %id) | ||
DB083247 | testis | .n | 1 to 547 | 2 to 548 | capped | 547/547 (100 %) | 0 diff (100 %id) | ||
DC408639 | thymus | .b | 1 to 541 | 3 to 545 | 545/545 (100 %) | 2 diff (99.7 %id) | |||
DB162397 | thymus | .i-u | 1 to 582 | 2 to 583 | capped | 582/582 (100 %) | 1 diff (99.9 %id) | ||
DB346947 | thymus | .i-u | 3090 to 3608 | 518 to 1 | 518/518 (100 %) | 2 diff (99.7 %id) | |||
TI_154034826 | .a | 2131 to 3092 | 1032 to 84 | AAA | 949/988 (96 %) | 27 diff (97.3 %id) | |||
TI_154056382 | .a | 2282 to 3092 | 896 to 94 | AAA | 803/996 (80 %) | 16 diff (98.4 %id) | |||
TI_154100187 | .i-u | 2915 to 3608 | 786 to 93 | AAA | 694/695 (99 %) | 14 diff (98.0 %id) | |||
TI_154102568 | .a | 2289 to 3092 | 882 to 82 | AAA | 801/804 (99 %) | 8 diff (99.1 %id) | |||
TI_154117184 | .a | 2383 to 3092 | 804 to 93 | AAA | 712/712 (100 %) | 9 diff (98.8 %id) | |||
TI_154129635 | .a | 2344 to 3092 | 836 to 92 | AAA | 745/982 (75 %) | 5 diff (99.5 %id) | |||
TI_154185460 | .a | 1708 to 2599 | 121 to 1004 | 884/1002 (88 %) | 26 diff (97.5 %id) | ||||
TI_154195911 | .c | 539 to 1346 | 81 to 878 | tiling clone, | 798/1011 (78 %) | 20 diff (98.1 %id) | |||
TI_154196335 | .a | 14 to 826 | 18 to 827 | 810/1081 (74 %) | 36 diff (96.7 %id) | ||||
TI_154197967 | .a | 16 to 923 | 106 to 1011 | 906/1021 (88 %) | 34 diff (96.7 %id) | ||||
TI_227713099 | .a | 2123 to 3092 | 1047 to 91 | AAA | 957/1028 (93 %) | 15 diff (98.6 %id) | |||
BP368222 | thymus | .a | 2015 to 2468 | 128 to 581 | 454/581 (78 %) | 2 diff (99.7 %id) | |||
DB205022 | trachea | .h | 143 to 715 | 2 to 574 | capped | 573/573 (100 %) | 1 diff (99.9 %id) | ||
DB348560 | trachea | .h | 1669 to 2213 | 544 to 1 | tiling clone, | 544/546 (99 %) | 3 diff (99.5 %id) | ||
U25801 | .l | 1 to 807 | 1 to 807 | A14P L20P Q128H H129D F155L | tiling clone, | 807/808 (99 %) | 7 diff (99.2 %id) | ||
BQ022977 | placenta | .b | 2660 to 2932 | 289 to 19 | AAA | 271/271 (100 %) | 2 diff (99.3 %id) | ||
BQ023947 | placenta | .b | 2469 to 2941 | 491 to 19 | AAA | 473/473 (100 %) | 3 diff (99.4 %id) | ||
CA503031 | Human Lung Epithelial cells, lung | .b | 2355 to 2941 | 604 to 19 | AAA | 586/587 (99 %) | 6 diff (99.0 %id) | ||
CA503031 | Human Lung Epithelial cells, lung | .b | 2355 to 2941 | 604 to 19 | AAA | 586/587 (99 %) | 6 diff (99.0 %id) | ||
BM716155 | eye, RPE and Choroid | .i-u | 1748 to 2444 | 1 to 697 | 697/697 (100 %) | 0 diff (100 %id) | |||
BM716155 | eye, RPE and Choroid | .i-u | 1748 to 2444 | 1 to 697 | 697/697 (100 %) | 0 diff (100 %id) | |||
BU732158 | eye, RPE and Choroid | .i-u | 2957 to 3608 | 670 to 19 | AAA | 652/652 (100 %) | 0 diff (100 %id) | ||
BU732158 | eye, RPE and Choroid | .i-u | 2957 to 3608 | 670 to 19 | AAA | 652/652 (100 %) | 0 diff (100 %id) | ||
BM672657 | eye, eye anterior segment | .a | 2773 to 3092 | 338 to 19 | AAA | 320/320 (100 %) | 1 diff (99.7 %id) | ||
BM672657 | eye, eye anterior segment | .a | 2773 to 3092 | 338 to 19 | AAA | 320/320 (100 %) | 1 diff (99.7 %id) | ||
BM687713 | eye, eye anterior segment | .a | 1916 to 2377 | 1 to 468 | 475/468 (101 %) | 10 diff (97.9 %id) | |||
BM687713 | eye, eye anterior segment | .a | 1916 to 2377 | 1 to 468 | 475/468 (101 %) | 10 diff (97.9 %id) | |||
BM712224 | eye, lens | .k | 518 to 920 | 1 to 403 | tiling clone, fully sequenced, | 403/403 (100 %) | 0 diff (100 %id) | ||
BM712224 | eye, lens | .k | 518 to 920 | 1 to 403 | tiling clone, fully sequenced, | 403/403 (100 %) | 0 diff (100 %id) | ||
BU737693 | eye, lens | .k | 890 to 1388 | 517 to 19 | tiling clone, fully sequenced, AAA | 499/499 (100 %) | 0 diff (100 %id) | ||
BU737693 | eye, lens | .k | 890 to 1388 | 517 to 19 | tiling clone, fully sequenced, AAA | 499/499 (100 %) | 0 diff (100 %id) | ||
CA441225 | Fibrosarcoma | .b | 2372 to 2941 | 588 to 19 | AAA | 570/570 (100 %) | 0 diff (100 %id) | ||
CA443836 | Fibrosarcoma | .a | 2397 to 3092 | 714 to 19 | AAA | 696/696 (100 %) | 0 diff (100 %id) | ||
CN479513 | Chondrosarcoma, Left Pubic Bone | .b | 2300 to 2941 | 659 to 19 | AAA | 641/647 (99 %) | 2 diff (99.7 %id) | ||
CN479513 | Chondrosarcoma, Left Pubic Bone | .b | 2300 to 2941 | 659 to 19 | AAA | 641/647 (99 %) | 2 diff (99.7 %id) | ||
BQ445932 | Knee, Osteoarthritic Cartilage | .b | 2288 to 2941 | 670 to 19 | AAA | 652/657 (99 %) | 4 diff (99.4 %id) | ||
BQ445932 | Knee, Osteoarthritic Cartilage | .b | 2288 to 2941 | 670 to 19 | AAA | 652/657 (99 %) | 4 diff (99.4 %id) | ||
CA418859 | Chondrosarcoma Grade II, Left Pelvis | .b | 2302 to 2941 | 657 to 19 | AAA | 639/639 (100 %) | 2 diff (99.7 %id) | ||
CA418859 | Chondrosarcoma Grade II, Left Pelvis | .b | 2302 to 2941 | 657 to 19 | AAA | 639/639 (100 %) | 2 diff (99.7 %id) | ||
BQ576264 | Chondrosarcoma Grade II, Left Pelvis | .b | 2348 to 2941 | 612 to 19 | AAA | 594/594 (100 %) | 1 diff (99.9 %id) | ||
BQ576264 | Chondrosarcoma Grade II, Left Pelvis | .b | 2348 to 2941 | 612 to 19 | AAA | 594/594 (100 %) | 1 diff (99.9 %id) | ||
CA749062 | cell lines, Chondrosarcoma | .b | 2361 to 2941 | 599 to 19 | AAA | 581/581 (100 %) | 1 diff (99.9 %id) | ||
CA749062 | cell lines, Chondrosarcoma | .b | 2361 to 2941 | 599 to 19 | AAA | 581/581 (100 %) | 1 diff (99.9 %id) | ||
CA307115 | Alveolar Macrophage, lung | .a | 2409 to 3092 | 702 to 19 | AAA | 684/684 (100 %) | 1 diff (99.9 %id) | ||
CA307115 | Alveolar Macrophage, lung | .a | 2409 to 3092 | 702 to 19 | AAA | 684/684 (100 %) | 1 diff (99.9 %id) | ||
CA307130 | Alveolar Macrophage, lung | .a | 2357 to 3092 | 754 to 19 | AAA | 736/736 (100 %) | 1 diff (99.9 %id) | ||
CA307130 | Alveolar Macrophage, lung | .a | 2357 to 3092 | 754 to 19 | AAA | 736/736 (100 %) | 1 diff (99.9 %id) | ||
CD367442 | Alveolar Macrophage, lung | .a | 2334 to 3092 | 774 to 19 | AAA | 756/756 (100 %) | 3 diff (99.7 %id) | ||
CD367442 | Alveolar Macrophage, lung | .a | 2334 to 3092 | 774 to 19 | AAA | 756/756 (100 %) | 3 diff (99.7 %id) | ||
CB528557 | Aveolar Macrophage, lung | .a | 2397 to 3092 | 714 to 19 | AAA | 696/696 (100 %) | 0 diff (100 %id) | ||
CB528557 | Aveolar Macrophage, lung | .a | 2397 to 3092 | 714 to 19 | AAA | 696/696 (100 %) | 0 diff (100 %id) | ||
TI_151769561 | .i-u | 1748 to 2307 | 109 to 673 | 565/888 (63 %) | 13 diff (98.6 %id) | ||||
DB257450 | uterus | .a | 1039 to 1618 | 2 to 581 | capped | 580/580 (100 %) | 1 diff (99.9 %id) |